Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improve Detection of ‘Winter Bugs’ with DiaSorin Molecular Technology

Published: Thursday, October 10, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
DiaSorin BUGS’n BEADS™ nucleic acid extraction kits for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

DiaSorin LIAISON® Ixt / Arrow BUGS’n BEADS™ extraction kits provide high yield, high purity nucleic acid preparations for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

As winter approaches, clinical laboratories are preparing for an increase in test requests for certain seasonal pathogens, such as norovirus and Mycoplasma pneumonia.

The DiaSorin BUGS’n BEADS™ nucleic acid extraction kits, for use with the automated DiaSorin LIAISON® Ixt / Arrow™ instruments, provide a highly purified nucleic acid preparation from patient samples for sensitive and accurate molecular confirmation of these microorganisms.

Outbreaks of norovirus, also known as winter vomiting disease, can spread quickly in certain semi-closed environments and frequently causes ward closures in hospitals during the winter months. Human noroviruses cannot be grown in cell culture and so diagnostic methods focus on the detection of viral RNA or antigen.

Mycoplasma pneumonia is a common cause of atypical pneumonia. Since other, less common etiological agents exist, which require a different course of treatment, identification of bacterial DNA in clinical samples has become increasingly important in establishing the cause of atypical pneumonia so that the optimal directed therapy can be provided for patients.

The sensitivity and accuracy of nucleic acid detection and amplification techniques can be reduced by interferences caused by the complexity of the sample matrix. The unique magnetic bead technology harnessed by the DiaSorin extraction kits overcomes this problem by concentrating the target microorganisms from a variety of sample matrices, including urine, sputum, culture and swabs, and then providing a highly purified nucleic acid extraction for downstream molecular analysis. No enzymatic pre-treatment or prior heat treatment is required.

The DiaSorin extraction kit solutions automate the purification and nucleic acid extraction process, reducing technician hands-on time and increasing sample throughput, making it ideal for the increasing workloads experienced during the winter months. The BUGS’n BEADS™ cartridges are simply loaded onto the LIAISON® Ixt / Arrow™ instrument for up to 12 patient samples and, in less than 45 minutes, a high yield, high purity nucleic acid preparation is then ready for use in a number of downstream applications.

DiaSorin BUGS’n BEADS™ can be used for the extraction of nucleic acid from a variety of pathogens, including Mycobacterium tuberculosis, enterovirus, MRSA, norovirus, Escherichia coli, Legionella, Mycoplasma pneumonia, Chlamydia pneumonia and Helicobacter pylori.

In addition to BUGS’n BEADS™, DiaSorin nucleic acid extraction kits are available for: the extraction of RNA or DNA; the extraction of DNA from stool and blood samples; and cell separation.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
“Sixth Sense” May Be More Than Just A Feeling
The NIH Study shows that two young patients with a mutation in the PIEZ02 have problems with touch and proprioception, or body awareness.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!